Epirus, Ranbaxy win Indian approval for arthritis drug

16-09-2014

Epirus, Ranbaxy win Indian approval for arthritis drug

CLIPAREA l Custom media / Shutterstock.com

Biopharmaceutical company Epirus has said that India’s drug regulator has approved a biosimilar application to produce a version of a popular arthritis treatment drug.


Ranbaxy, Epirus, pharmaceutical, biosimilar, Remicade

LSIPR